• Return to Headlines

Recent 52-Week High Exceeded in Shares of Amgen Inc (AMGN)

By Shiri Gupta

Amgen Inc (NASDAQ:AMGN) traded today at a new 52-week high of $204.32. This new high was reached on below average trading volume as 376,000 shares traded hands, while the average 30-day volume is approximately 2.1 million shares.

Amgen Inc (NASDAQ:AMGN) is currently priced 3.7% above its average consensus analyst price target of $196.70. Amgen Inc shares have support at the 50-day moving average (MA) of $195.81 and additional support at the 200-day MA of $183.63.

Over the past year, Amgen Inc has traded in a range of $163.31 to $204.32 and is now at $204.30, 25% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.7%.

Amgen Inc. is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. The Company focuses solely on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology.

SmarTrend recommended that subscribers consider buying shares of Amgen Inc on May 22nd, 2018 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $178.04. Since that recommendation, shares of Amgen Inc have risen 14.0%. We continue to monitor AMGN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows amgen inc

Ticker(s): AMGN